← FDA Drug Approvals (Drugs@FDA)
LORAZEPAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2017-04-04
Drug application
- FDA Application #
ANDA200217- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LORAZEPAM
- Generic name
- Lorazepam
- Active ingredients
- LORAZEPAM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- RISING
- First approval
- 2017-04-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown